Jacques Eisenberg

1.5k total citations
15 papers, 695 citations indexed

About

Jacques Eisenberg is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jacques Eisenberg has authored 15 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jacques Eisenberg's work include Attention Deficit Hyperactivity Disorder (12 papers), Bipolar Disorder and Treatment (8 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Jacques Eisenberg is often cited by papers focused on Attention Deficit Hyperactivity Disorder (12 papers), Bipolar Disorder and Treatment (8 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Jacques Eisenberg collaborates with scholars based in Israel, United States and Germany. Jacques Eisenberg's co-authors include Richard P. Ebstein, Iris Manor, Moshe Kotler, Yonathan Sever, Hagit Cohen, Inga Gritsenko, Lubov Nemanov, Ada H. Zohar, Avraham Steinberg and Samuel Tyano and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

Jacques Eisenberg

15 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Eisenberg Israel 10 509 302 214 111 86 15 695
Monika Deschner Germany 6 342 0.7× 258 0.9× 174 0.8× 166 1.5× 62 0.7× 7 591
Naomi Lowe Ireland 11 684 1.3× 418 1.4× 279 1.3× 114 1.0× 137 1.6× 16 915
Vittorio Di Michele Italy 12 436 0.9× 321 1.1× 146 0.7× 173 1.6× 25 0.3× 24 775
H.‐G. Weijers Germany 14 309 0.6× 321 1.1× 231 1.1× 176 1.6× 26 0.3× 18 853
Valeria Rubino Italy 7 217 0.4× 419 1.4× 171 0.8× 81 0.7× 75 0.9× 8 687
Cali Bartholomeusz Australia 12 410 0.8× 209 0.7× 93 0.4× 168 1.5× 69 0.8× 20 772
Terry E. Goldberg United States 7 861 1.7× 518 1.7× 105 0.5× 160 1.4× 116 1.3× 8 1.1k
G. Reiter United States 8 1.2k 2.3× 670 2.2× 129 0.6× 258 2.3× 87 1.0× 12 1.4k
A. Marten H. Onnink Netherlands 18 626 1.2× 623 2.1× 89 0.4× 75 0.7× 59 0.7× 21 913
Jennifer Mohr United States 7 550 1.1× 420 1.4× 263 1.2× 246 2.2× 87 1.0× 8 871

Countries citing papers authored by Jacques Eisenberg

Since Specialization
Citations

This map shows the geographic impact of Jacques Eisenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Eisenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Eisenberg more than expected).

Fields of papers citing papers by Jacques Eisenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Eisenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Eisenberg. The network helps show where Jacques Eisenberg may publish in the future.

Co-authorship network of co-authors of Jacques Eisenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Eisenberg. A scholar is included among the top collaborators of Jacques Eisenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Eisenberg. Jacques Eisenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Eisenberg, Jacques, et al.. (2011). Heart rate variability during a continuous performance test in children with problems of attention.. PubMed. 48(1). 19–24. 4 indexed citations
2.
Manor, Iris, Efrat Laiba, Jacques Eisenberg, et al.. (2008). Association between trypotphan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(8). 1501–1508. 21 indexed citations
3.
Asherson, Philip, Keeley J. Brookes, Barbara Franke, et al.. (2007). Confirmation That a Specific Haplotype of the Dopamine Transporter Gene Is Associated With Combined-Type ADHD. American Journal of Psychiatry. 164(4). 674–677. 86 indexed citations
4.
Manor, Iris, Marilys Corbex, Jacques Eisenberg, et al.. (2004). Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 127B(1). 73–77. 43 indexed citations
5.
Eisenberg, Jacques, et al.. (2004). An autonomic nervous system biofeedback modality for the treatment of attention deficit hyperactivity disorder--an open pilot study.. PubMed. 41(1). 45–53. 8 indexed citations
6.
Manor, Iris, Jacques Eisenberg, Samuel Tyano, et al.. (2001). Family‐based association study of the serotonin transporter promoter region polymorphism (5‐HTTLPR) in attention deficit hyperactivity disorder. American Journal of Medical Genetics. 105(1). 91–95. 4 indexed citations
7.
Manor, Iris, Jacques Eisenberg, S. Tyano, et al.. (2001). Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. American Journal of Medical Genetics. 105(1). 91–95. 139 indexed citations
8.
Eisenberg, Jacques, Ada H. Zohar, Avraham Steinberg, et al.. (2000). A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). American Journal of Medical Genetics. 96(3). 258–261. 65 indexed citations
9.
Manor, Iris, Moshe Kotler, Yonathan Sever, et al.. (2000). Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. American Journal of Medical Genetics. 96(6). 858–860. 34 indexed citations
10.
Kotler, Moshe, Iris Manor, Yonathan Sever, et al.. (2000). Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. American Journal of Medical Genetics. 96(3). 278–281. 68 indexed citations
11.
Eisenberg, Jacques, Avraham Steinberg, Ada H. Zohar, et al.. (1999). Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with adhd impulsive-hyperactive phenotype. American Journal of Medical Genetics. 88(5). 497–502. 131 indexed citations
12.
13.
Asnis, Gregory M., Jacques Eisenberg, Herman M. van Praag, et al.. (1988). The neuroendocrine response to fenfluramine in depressives and normal controls. Biological Psychiatry. 24(1). 117–120. 59 indexed citations
14.
Lemus, Carmen Z., Gregory M. Asnis, Uriel Halbreich, et al.. (1987). Clinical variables and hypothalamic-pituitary-adrenal function in depression. Journal of Affective Disorders. 12(3). 219–221. 5 indexed citations
15.
Asnis, Gregory M., Jacques Eisenberg, Carmen Z. Lemus, & Uriel Halbreich. (1986). Dexamethasone Suppression Test in Schizophrenia. Neuropsychobiology. 15(3-4). 109–113. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026